Skip to main content
. 2020 Nov 3;5(11):e002640. doi: 10.1136/bmjgh-2020-002640

Figure 1.

Figure 1

Percentages of individuals with high CVD risk from communities where three types of CVD medicines are available (left) and affordable (right). CVD, cardiovascular disease; HIC, high-income countries; LICs, low-income countries; LMICs, lower middle-income countries; UMICs, upper middle-income countries.